NeOnc Technologies Holdings, Inc. (NTHI), a multi-Phase 2 clinical-stage biopharmaceutical company, Tuesday announced the appointment of Amir Heshmatpour as Chief Executive Officer.
Heshmatpour has been serving as President since April. He will continue to serve as Executive Chairman. Heshmatpour brings over 25 years of senior executive and board-level experience
The company's founder Thomas Chen will transition from the CEO role and will focus exclusively on his positions as Chief Medical Officer, Chief Scientific Officer, and member of the Board.
Previously, Heshmatpour had served as Chairman and CEO of Metrophone Telecommunications.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.